Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Comparison of methods for assessing the severity of multiple sclerosis based on a sample of patients from the Moscow region].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

[Molecular mechanisms of acute disseminated encephalomyelitis].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

[Results of a 5-year project for the early diagnosis of multiple sclerosis in first-line blood relatives (RADIRS program)].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

[Quantitative analysis of cerebrospinal fluid flow in multiple sclerosis patients].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

[Results of 4 years of therapy with divozilimab in patients with relapsing multiple sclerosis].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

[Eculizumab in the treatment of neuromyelitis optica spectrum disorder].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025

Related Experiment Video

Updated: Jun 1, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.9K

[Questionnaires for arm function assessment in patients with multiple sclerosis].

A N Boyko1,2, A N Belova3, E M Rahmanova3

  • 1Pirogov National Medical Research University, Moscow, Russia.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|July 29, 2024
PubMed
Summary

Assessing upper limb function in multiple sclerosis (MS) is crucial for patient care. This review details questionnaires, including the Arm Function in Multiple Sclerosis Questionnaire (AMSQ), to evaluate arm dysfunction in MS patients.

Keywords:
armassessmentfunctionmultiple sclerosisquestionnaireupper limb

More Related Videos

An Objective and Child-friendly Assessment of Arm Function by Using a 3-D Sensor
07:25

An Objective and Child-friendly Assessment of Arm Function by Using a 3-D Sensor

Published on: February 12, 2018

6.9K
Therapy Interventions for Upper Limb Amputees Undergoing Selective Nerve Transfers
07:59

Therapy Interventions for Upper Limb Amputees Undergoing Selective Nerve Transfers

Published on: October 29, 2021

3.4K

Related Experiment Videos

Last Updated: Jun 1, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.9K
An Objective and Child-friendly Assessment of Arm Function by Using a 3-D Sensor
07:25

An Objective and Child-friendly Assessment of Arm Function by Using a 3-D Sensor

Published on: February 12, 2018

6.9K
Therapy Interventions for Upper Limb Amputees Undergoing Selective Nerve Transfers
07:59

Therapy Interventions for Upper Limb Amputees Undergoing Selective Nerve Transfers

Published on: October 29, 2021

3.4K

Area of Science:

  • Neurology
  • Rehabilitation Medicine
  • Clinical Assessment

Background:

  • Arm dysfunction is a significant disabling symptom in multiple sclerosis (MS), particularly in advanced stages.
  • Objective assessment of upper limb function is vital for tracking MS progression, evaluating treatment efficacy, and tailoring rehabilitation strategies.
  • Patient-reported outcome measures (PROMs), such as questionnaires, are important for a patient-centered approach to MS management.

Purpose of the Study:

  • To review existing questionnaires used for assessing upper limb function in multiple sclerosis patients.
  • To highlight the importance of patient-reported outcomes in managing MS-related arm dysfunction.
  • To provide a detailed overview of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ).

Main Methods:

  • Literature review of multidimensional and unidimensional questionnaires for upper limb function assessment in MS.
  • Description of three MS-specific and four MS-nonspecific questionnaires.
  • Detailed discussion of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ).

Main Results:

  • Several questionnaires are available to assess upper limb dysfunction in MS patients.
  • Patient-reported outcome measures offer valuable insights into patient experiences and preferences.
  • The AMSQ is a disease-specific tool designed to evaluate arm function in MS, with its application in Russian populations requiring cultural adaptation and validation.

Conclusions:

  • Accurate assessment of upper limb function is essential for effective multiple sclerosis management.
  • Patient-centered questionnaires, like the AMSQ, play a key role in evaluating arm dysfunction and guiding rehabilitation.
  • Cultural adaptation and validation are necessary steps before implementing tools like the AMSQ in new linguistic populations.